5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.27%
Positive revenue growth while UPM.HE is negative. John Neff might see a notable competitive edge here.
145.19%
Positive gross profit growth while UPM.HE is negative. John Neff would see a clear operational edge over the competitor.
543.28%
EBIT growth above 1.5x UPM.HE's 185.92%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
543.28%
Operating income growth above 1.5x UPM.HE's 185.92%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
380.33%
Net income growth under 50% of UPM.HE's 1837.50%. Michael Burry would suspect the firm is falling well behind a key competitor.
411.36%
EPS growth under 50% of UPM.HE's 1833.33%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
411.36%
Diluted EPS growth under 50% of UPM.HE's 1833.33%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-6.09%
Share reduction while UPM.HE is at 0.11%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-6.09%
Reduced diluted shares while UPM.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-56.26%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-83.99%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-14.10%
Negative 10Y revenue/share CAGR while UPM.HE stands at 6.46%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-15.06%
Negative 5Y CAGR while UPM.HE stands at 18.83%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-9.93%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
572.66%
10Y OCF/share CAGR above 1.5x UPM.HE's 7.50%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
173.52%
Positive OCF/share growth while UPM.HE is negative. John Neff might see a comparative advantage in operational cash viability.
8.39%
Positive 3Y OCF/share CAGR while UPM.HE is negative. John Neff might see a big short-term edge in operational efficiency.
125.94%
Positive 10Y CAGR while UPM.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
50.00%
Below 50% of UPM.HE's 115.81%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
282.40%
3Y net income/share CAGR above 1.5x UPM.HE's 30.51%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-4.37%
Negative 5Y equity/share growth while UPM.HE is at 15.86%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
19.97%
3Y equity/share CAGR above 1.5x UPM.HE's 6.24%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while UPM.HE stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
34.60%
AR growth well above UPM.HE's 46.10%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.72%
Inventory shrinking or stable vs. UPM.HE's 11.25%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
6.86%
Asset growth above 1.5x UPM.HE's 2.77%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
18.20%
BV/share growth above 1.5x UPM.HE's 4.22%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.72%
We have some new debt while UPM.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
4.05%
We expand SG&A while UPM.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.